Skip to main content

Table 1 Impact of confounding by gender, age, and comorbidity on the association between GEC and mortality of cirrhosis patients, estimated with Cox proportional hazards regression.

From: The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study

   Crude HR (95% CI) Adjusted HR (95% CI)
GEC < 1.75 mmol/min    
  GEC, per 0.5 mmol/min 0.74 (0.59–0.92) 0.64 (0.51–0.81)
  Male vs. female 1.31 (1.06–1.63) 1.41 (1.13–1.76)
  Age, per decade 1.22 (1.11–1.35) 1.20 (1.09–1.32)
  Comorbidity, CCI ≥ 1 vs. 0 1.40 (1.11–1.78) 1.37 (1.08–1.75)
GEC ≥ 1.75 mmol/min    
  GEC, per 0.5 mmol/min 0.79 (0.59–1.05) 0.80 (0.60–1.08)
  Male vs. female 1.46 (0.87–2.46) 1.44 (0.86–2.43)
  Age, per decade 1.28 (1.07–1.52) 1.23 (1.02–1.48)
  Comorbidity, CCI ≥ 1 vs. 0 1.59 (1.08–2.35) 1.42 (0.95–2.12)
  1. Comorbidity is defined by the Charlson comorbidity index (CCI). Associations are expressed as hazard ratios (HR) and presented without adjustment (Crude HR) and with adjustment for the potential confounders.